45 In the index

Memantine MEMA

An FDA-approved Alzheimer's medication for moderate-to-severe disease. Human studies support modest improvements in thinking and daily function at that stage, with a good tolerability record compared to other Alzheimer's drugs.

Also known as Namenda

Effects Focus

Routes Oral

Legal status Prescription drug

WADA Not listed

3D Molecular Structure of C₁₂H₂₁N

Drag to rotate · scroll to zoom

Chemistry

Formula: C12H21N
Molar mass: 179.30
CAS: 19982-08-2
PubChem CID: 4054

Reported dosing

Approved label

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 10 mg twice daily (target dose, after titration)

Reported range 5-28 mg/day depending on formulation

Route Oral

Frequency Once or twice daily

Duration Chronic/ongoing (as prescribed)

FDA-approved NMDA receptor antagonist (Namenda) for moderate-to-severe Alzheimer's disease.

Where this comes from FDA prescribing information

These figures are recorded for reference and are not a recommendation. Dosing is a decision for you and a clinician.